查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1458134

肿瘤消融的全球市场规模、份额和成长分析：按技术、治疗和应用分类 - 产业预测（2024-2031）

Global Tumor Ablation Market Size, Share, Growth Analysis, By Technology(Radiofrequency Ablation, Microwave Ablation), By Treatment(Surgical Ablation, Laparoscopic Ablation), By Application(Kidney Cancer, Liver Cancer) - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球肿瘤消融市场规模将估值为14.8亿美元，从2023年的16.8亿美元扩大到2031年的46.3亿美元，并将在预测期内（2024-2031年）增长。年复合增长率为13.5%。

推动市场扩张的两个主要因素是癌症发生率上升和对更安全治疗选择的强烈需求。世界卫生组织（WHO）预测，到2030年，全球每年将新增1,000至1,100万名癌症病例。低收入国家的新发癌症发生率预计将增加 80% 以上，而高所得国家的发生率预计将减半至 40%。对微创和非侵入性治疗的强烈需求以及现有治疗方法进步的良好潜力预计将在未来几年推动市场发展。

在预测期内，由于外科医生和患者对微创手术的偏好不断增加，对先进肿瘤切除技术的需求可能会增加，因为微创手术具有缩短恢復时间、提高患者舒适度和缩短週转时间等优点。与传统治疗相比，先进的肿瘤切除术通常作为门诊病人手术进行，无需住院，因此整体费用便宜得多。对于小肿瘤，辅助手术是主要的治疗策略。因此，每年的癌症检出率对手术数量有间接影响。 2020年，由于相关部门在COVID-19期间进行的筛检次数减少，新诊断癌症病例数有所减少，这对市场产生了重大影响。

全球变迁数据实验室的数据世界 (OWD)倡议进行的一项研究发现，超过 70% 的癌症诊断发生在 50 岁及以上的人群中。随着人口老化，这个数字可能会增加。老龄化人口是无创消融手术的主要目标群。因此，由于老年人口的增加，预计在预测期内对肿瘤消融手术的需求将会增加。

提高精度、便携性和成本经济性的技术正在推动市场参与者不断创新和推出尖端产品。这些技术进步包括冷冻、HIFU 和影像导引设备。使用冷却射频修改，即使用外部冷却射频探头来扩大病变的大小，是即将到来的方法之一，预计将在市场扩张中发挥重要作用。这种治疗可以使骶髂关节完全退化，从而缓解疼痛。

目录

执行摘要

  • 市场概况
  • 转型

调查方法

  • 资讯采购
  • 次要/一级资讯来源
  • 市场规模估算
  • 市场假设与限制

母市场分析

  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务

主要市场考察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • Start-Ups分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 主要投资分析
  • 关键成功因素
  • 竞争程度

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 监管环境
  • 波特的分析
  • 对未来中断的特殊考虑

全球肿瘤消融市场：依技术划分

  • 市场概况
  • 射频消融术
  • 微波消融
  • 冷冻
  • 不可逆电穿孔消融
  • 其他消融技术

全球肿瘤消融市场：依治疗分类

  • 市场概况
  • 手术消融
  • 腹腔镜消融术
  • 经皮消融术

全球肿瘤消融市场：依应用分类

  • 市场概况
  • 肾癌
  • 肝癌
  • 乳癌
  • 肺癌
  • 摄护腺癌
  • 其他癌症

全球肿瘤消融市场规模（按地区）

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲

竞争格局

  • 前5名企业对比
  • 主要企业市场定位（2021年）
  • 主要市场参与者所采取的策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率（2021年）

主要企业简介

  • Medtronic plc
  • Boston Scientific Corporation
  • Johnson & Johnson（Ethicon, Inc.）
  • AngioDynamics, Inc.
  • EDAP TMS SA
  • SonaCare Medical, LLC
  • Merit Medical Systems, Inc.
  • Misonix, Inc.
  • HealthTronics, Inc.
  • Galil Medical Ltd.
  • IceCure Medical Ltd.
  • Monteris Medical, Inc.
  • Perseon Corporation
  • NeuWave Medical（Johnson & Johnson）
  • MedWaves, Inc.
  • Hologic, Inc.
  • Sonacare Inc.（HIFU division）
  • Symple Surgical Inc.
  • BVM Medical Limited
  • Misonix, Inc.
简介目录
Product Code: SQMIG35A2494

Global Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% during the forecast period (2024-2031).

Two key factors propelling market expansion are the rising incidence of cancer and the strong need for safer treatment options. The World Health Organization (WHO) projects that 10-11 million new cases of cancer will be diagnosed worldwide annually by 2030. It is projected that the rate of new cancer cases in low-income countries would increase by over 80%, while the rate in high-income countries will climb at a rate of half (40%). The market is expected to be driven in the upcoming years by a strong need for minimally invasive and non-invasive therapies, as well as by lucrative potential for development in already available therapeutic choices.

Over the projection period, there will likely be an increase in demand for advanced tumor ablation technologies due to surgeons' and patients' rising preference for minimally invasive procedures because of advantages such quicker recovery times, more patient comfort, and shorter turnaround times. Advanced tumor ablation operations are significantly less expensive overall since they are typically performed as outpatient procedures without a hospital stay, in contrast to traditional therapy. For small tumors, adjuvant surgeries are the main course of treatment. Thus, annual cancer detection rates have an indirect impact on its procedure number. 2020 saw a substantial influence on the market as fewer new cancer cases were diagnosed during COVID-19 as a result of fewer screenings conducted by relevant authorities.

In a survey conducted by Global Change Data Lab's Our World in Data (OWD) initiative, people over 50 accounted for more than 70% of cancer diagnoses. The number is probably going to increase in lockstep with the aging population. When it comes to noninvasive ablation operations, the aging population is the major target group because as people age, their basic systems weaken. Therefore, over the projection period, it is anticipated that the growing aging population will increase demand for tumor ablation procedures.

Technologies that increase precision, portability, and economy of cost are what push market players to continuously innovate and introduce cutting-edge products. These technological advancements include cryoablation, HIFU, and image-guided devices. The use of the cooled radiofrequency degeneration technique with externally chilled radiofrequency probes to expand the size of the lesion is one of the forthcoming approaches that is anticipated to play a major role in market expansion. Pain can be relieved by this treatment, which permits complete degeneration of the sacroiliac joint.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tumor Ablation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tumor Ablation Market Segmental Analysis

Based on end user, region, technology, and application, the global market for tumor ablation is divided into segments. The market is divided into segments according to technology: cryoablation, irreversible electroporation ablation, microwave ablation, radiofrequency ablation, and other ablation methods. The market is divided into three segments based on the type of ablation: percutaneous, laparoscopic, and surgical. The market is divided into categories for kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and other cancers based on the application. The global market for tumor ablation is divided into five regions: North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Tumor Ablation Market

The market for tumor ablation is significantly influenced by the increased incidence of cancer worldwide, especially in relation to lung, liver, kidney, and breast malignancies. For patients who may not be good candidates for surgery, tumor ablation procedures provide minimally invasive alternatives to surgery for the treatment of localized tumors.

Restraints in the Global Tumor Ablation Market

Procedures for tumor ablation can be costly, particularly when cutting-edge technologies and imaging guidance are used. Tumor ablation treatments may not be as widely available in developing countries due to the high cost of specialist healthcare personnel, equipment, and consumables.

Market Trends of the Global Tumor Ablation Market

Technological Developments: The market for tumor ablation is seeing a steady stream of technological developments that are resulting in the creation of more sophisticated and accurate ablation methods. These developments include the utilization of robotic systems for increased accuracy, the creation of new energy sources for ablation, and the integration of imaging modalities for real-time guidance. Tumor ablation operations are now safer and more effective because to these technological improvements.

Growing Adoption of Minimally Invasive Procedures: Compared to standard surgical techniques, minimally invasive tumor ablation procedures are becoming more and more common. The use of minimally invasive procedures is being fueled by its benefits, which include fewer incisions, shorter hospital stays, quicker healing times, and a decreased risk of complications. As a less intrusive therapeutic alternative, minimally invasive tumor ablation techniques are becoming more and more popular among patients and healthcare professionals.

Growth in Cancer Prevalence: The market for tumor ablation is significantly influenced by the rising prevalence of cancer in the world. The increasing number of cancer cases, including those of the liver, lung, kidney, and prostate, is driving up need for efficient treatment solutions. When treating localized tumors, tumor ablation techniques present a less invasive alternatives to surgery, making them a feasible therapeutic option for patients who might not be good candidates for surgery.

Growing Interest in Precision Medicine: In oncology, precision medicine-which entails customizing treatment based on unique patient characteristics-is becoming more and more popular. Because tumor ablation techniques can target particular tumor areas while protecting healthy tissues, they are a good fit with the precision medicine principles. Tumor ablation is a desirable treatment method in the era of precision medicine because it can give targeted therapy with little effect on neighboring tissues.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Tumor Ablation Market by Technology

  • Market Overview
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation Ablation
  • and Other Ablation Technologies

Global Tumor Ablation Market by Treatment

  • Market Overview
  • Surgical Ablation
  • Laparoscopic Ablation
  • and Percutaneous Ablation

Global Tumor Ablation Market by Application

  • Market Overview
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • and Other Cancer

Global Tumor Ablation Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (Ethicon, Inc.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EDAP TMS S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SonaCare Medical, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Misonix, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HealthTronics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Galil Medical Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IceCure Medical Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Monteris Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Perseon Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuWave Medical (Johnson & Johnson)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedWaves, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sonacare Inc. (HIFU division)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Symple Surgical Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BVM Medical Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Misonix, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments